VANGUARD GROUP INC, a registered investment adviser, initiated a new position in Exact Sciences Corporation (NASDAQ:EXAS) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 15,975,851 shares of the Healthcare company, valued at approximately $1.6B as of the filing date.
Exact Sciences Corporation's stock currently trades at $102.39 with a market capitalization of $19.2B.